| Clinical, biological and therapeutic variable | Adherence n (%) | Non-adherence n (%) | Total n (%) | p |
| CDC Clinical stage | 0.12 | |||
| Stage A | 52 (52.5) | 28 (41.8) | 80 (48.2) |
|
| Stage B | 34 (34.3) | 30 (44.8) | 64 (38.6) |
|
| Stage C | 13 (13.2) | 9 (13.4) | 22 (13.2) |
|
| CD4 inclusion rate |
| 0.05 | ||
| ≤200 | 19 (19.2) | 6 (9.0) | 25 (15.1) |
|
| 200 - 500 | 27 (27.3) | 19 (28.4) | 46 (27.7) |
|